Gene: VPS54
Official Full Name: VPS54 subunit of GARP complexprovided by HGNC
Gene Summary: This gene encodes for a protein that in yeast forms part of a trimeric vacuolar-protein-sorting complex that is required for retrograde transport of proteins from prevacuoles to the late Golgi compartment. As in yeast, mammalian Vps54 proteins contain a coiled-coil region and dileucine motifs. Alternative splicing results in multiple transcript variants encoding different isoforms [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22417 | VPS54 Knockout cell line (HeLa) | Human | VPS54 | 1:3~1:6 | Negative | Online Inquiry |
KO22418 | VPS54 Knockout cell line (HCT 116) | Human | VPS54 | 1:2~1:4 | Negative | Online Inquiry |
KO22419 | VPS54 Knockout cell line (HEK293) | Human | VPS54 | 1:3~1:6 | Negative | Online Inquiry |
KO22420 | VPS54 Knockout cell line (A549) | Human | VPS54 | 1:3~1:4 | Negative | Online Inquiry |
VPS54 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the VPS54 gene, a crucial component of the conserved endosomal and lysosomal pathways in eukaryotic cells. This product enables researchers to study the functional role of VPS54 in cellular processes such as membrane trafficking, autophagy, and signal transduction. The absence of this gene allows for the exploration of pathways and mechanisms that are otherwise masked by normal VPS54 expression, thereby illuminating the contributions of this protein to various biological phenomena.
The VPS54 protein is integral to the formation of the GARP complex, which is essential for the retrograde transport of proteins from early endosomes to the trans-Golgi network. With VPS54 Gene Knockout Cell Lines, researchers can delve into the effects of VPS54 loss on cellular homeostasis, protein processing, and the potential implications in diseases such as neurodegeneration and cancer. This tool holds significant promise for investigating therapeutic targets and understanding pathological conditions where endosomal malfunction occurs.
One of the product's unique advantages is the precision of the gene knockout approach, which minimizes off-target effects commonly associated with alternative methods such as RNA interference. This provides a robust platform for definitive analysis and validation of VPS54’s role in various biological contexts. By utilizing these specialized cell lines, researchers can achieve more reliable results, leading to insights that contribute to advancing knowledge in cell biology and potential therapeutic interventions.
In addition, VPS54 Gene Knockout Cell Lines are developed with stringent quality control measures and rigorous validation processes, ensuring their reliability and reproducibility in experiments. As experts in creating biological products with a focus on cutting-edge genetic models, our company is dedicated to equipping researchers and clinicians with innovative tools that drive scientific discovery and clinical advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.